Paediatric asthma Respiratory
Conditions
Interventions
This is a parallel-group, cluster-randomised controlled trial with a waiting-list control design.
General practices across Hampshire, the Isle of Wight and the Thames Valley region will act as parti
Sponsors
University Hospital Southampton NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Children aged 1-17 years old 2. 7 or more prescriptions of SABA inhalers e.g. salbutamol during the qualifying period (previous 12 months for the intervention group, 24-12 months previously for the control group) 3. Informed consent from parent/guardian/participant with assent from participant where appropriate (Children do not need to have a recorded diagnosis of asthma to be eligible to participate in the project)
Exclusion criteria
Exclusion criteria: 1. Other (in addition to asthma) long-term respiratory condition e.g. cystic fibrosis. 2. Enrolled in another interventional research study. 3. Participant or parent/guardian unable to communicate sufficiently (with an interpreter where available) to complete consent forms and have an asthma review.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of severe asthma attacks measured using data collected from medical records during the 12 months following the asthma review (intervention group), or during the 12 months before the asthma review (control group) | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcomes will be measured using data collected from medical records during the 12 months following the asthma review (intervention group), or the 12 months before the asthma review (control group): 1. Number of SABA inhalers prescribed 2. Asthma treatment including inhaled corticosteroid dose 3. Number of hospital admissions due to asthma 4. Asthma-related health care visits in primary and secondary care (including ED attendances). Health economic evaluation: Healthcare costs and benefits will be compared in the intervention and control groups. This will cover the cost of the intervention, asthma medications, scheduled and unscheduled asthma-related primary care visits, asthma-related ED visits, inpatient care and outpatient hospital care. Process evaluation: 1. The views of 20-30 parents and 10-15 young people (aged 12 or more) from the intervention arm will be collected approximately one month after their involvement in the project 2. The views of 10-15 healthcare professionals from intervention practices will be collected at the end of the practice's involvement in the project | — |
Countries
England, United Kingdom
Contacts
Public ContactAnna Selby
Outcome results
None listed